DOVATO clinical trials

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

This study looks at switching HIV patients already on opioid addiction treatment to a new HIV medicine called Dovato. We want to see if Dovato keeps their HIV under control and if it's safe for them.